Literature DB >> 12525653

Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants.

Daniel N Streblow1, Craig Kreklywich, Qiang Yin, V T De La Melena, Christopher L Corless, Patricia A Smith, Christina Brakebill, Judith W Cook, Cornelis Vink, Cathrien A Bruggeman, Jay A Nelson, Susan L Orloff.   

Abstract

Cytomegalovirus (CMV) infections have been shown to dramatically affect solid organ transplant graft survival in both human and animal models. Recently, it was demonstrated that rat CMV (RCMV) infection accelerates the development of transplant vascular sclerosis (TVS) in both rat heart and small bowel graft transplants. However, the mechanisms involved in this process are still unclear. In the present study, we determined the kinetics of RCMV-accelerated TVS in a rat heart transplant model. Acute RCMV infection enhances the development of TVS in rat heart allografts, and this process is initiated between 21 and 24 days posttransplantation. The virus is consistently detected in the heart grafts from day 7 until day 35 posttransplantation but is rarely found at the time of graft rejection (day 45 posttransplantation). Grafts from RCMV-infected recipients had upregulation of chemokine expression compared to uninfected controls, and the timing of this increased expression paralleled that of RCMV-accelerated neointimal formation. In addition, graft vessels from RCMV-infected grafts demonstrate the increased infiltration of T cells and macrophages during periods of highest chemokine expression. These results suggest that CMV-induced acceleration of TVS involves the increased graft vascular infiltration of inflammatory cells through enhanced chemokine expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525653      PMCID: PMC140920          DOI: 10.1128/jvi.77.3.2182-2194.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  Regulation and tissue-specific expression of human cytomegalovirus.

Authors:  J A Nelson; J W Gnann; P Ghazal
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection.

Authors:  W T van Dorp; E Jonges; C A Bruggeman; M R Daha; L A van Es; F J van Der Woude
Journal:  Transplantation       Date:  1989-09       Impact factor: 4.939

3.  The use of cytomegalovirus-screened blood in neonates.

Authors:  G E Tegtmeier
Journal:  Transfusion       Date:  1988 May-Jun       Impact factor: 3.157

4.  Cytomegalovirus infection of human blood cells.

Authors:  L Einhorn; A Ost
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

5.  A rat small bowel transplant model of chronic rejection: histopathologic characteristics.

Authors:  S L Orloff; Q Yin; C L Corless; C B Loomis; J M Rabkin; C R Wagner
Journal:  Transplantation       Date:  1999-09-27       Impact factor: 4.939

Review 6.  Cardiac allograft vasculopathy: current concepts, recent developments, and future directions.

Authors:  J D Hosenpud; G D Shipley; C R Wagner
Journal:  J Heart Lung Transplant       Date:  1992 Jan-Feb       Impact factor: 10.247

7.  Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

8.  Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Biology of rat cytomegalovirus infection.

Authors:  C A Bruggeman; H Meijer; F Bosman; C P van Boven
Journal:  Intervirology       Date:  1985       Impact factor: 1.763

10.  A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation.

Authors:  T C Merigan; D G Renlund; S Keay; M R Bristow; V Starnes; J B O'Connell; S Resta; D Dunn; P Gamberg; R M Ratkovec
Journal:  N Engl J Med       Date:  1992-04-30       Impact factor: 91.245

View more
  31 in total

1.  Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells.

Authors:  Cynthia A Bolovan-Fritts; Rodney N Trout; Stephen A Spector
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 2.  The role of cytomegalovirus in angiogenesis.

Authors:  Patrizia Caposio; Susan L Orloff; Daniel N Streblow
Journal:  Virus Res       Date:  2010-10-01       Impact factor: 3.303

3.  Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro.

Authors:  Daniel N Streblow; Koen W R van Cleef; Craig N Kreklywich; Christine Meyer; Patricia Smith; Victor Defilippis; Finn Grey; Klaus Früh; Robert Searles; Cathrien Bruggeman; Cornelis Vink; Jay A Nelson; Susan L Orloff
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

4.  High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage.

Authors:  Cynthia A Bolovan-Fritts; Rodney N Trout; Stephen A Spector
Journal:  Blood       Date:  2007-05-22       Impact factor: 22.113

5.  Fluorescence-based laser capture microscopy technology facilitates identification of critical in vivo cytomegalovirus transcriptional programs.

Authors:  Craig N Kreklywich; Patricia P Smith; Carmen Baca Jones; Anda Cornea; Susan L Orloff; Daniel N Streblow
Journal:  Methods Mol Biol       Date:  2014

6.  Identifying the molecular and cellular signature of cardiac dilation following myocardial infarction.

Authors:  Merry L Lindsey; Yonggang Ma; Elizabeth R Flynn; Michael D Winniford; Michael E Hall; Kristine Y DeLeon-Pennell
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-20       Impact factor: 5.187

Review 7.  Acceleration of allograft failure by cytomegalovirus.

Authors:  Daniel N Streblow; Susan L Orloff; Jay A Nelson
Journal:  Curr Opin Immunol       Date:  2007-08-22       Impact factor: 7.486

8.  Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors.

Authors:  Dennis Verzijl; Stefania Storelli; Danny J Scholten; Leontien Bosch; Todd A Reinhart; Daniel N Streblow; Cornelis P Tensen; Carlos P Fitzsimons; Guido J R Zaman; James E Pease; Iwan J P de Esch; Martine J Smit; Rob Leurs
Journal:  J Pharmacol Exp Ther       Date:  2008-02-12       Impact factor: 4.030

9.  Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction.

Authors:  Cynthia A Bolovan-Fritts; Stephen A Spector
Journal:  Blood       Date:  2007-09-25       Impact factor: 22.113

10.  Cytomegalovirus CC chemokine promotes immune cell migration.

Authors:  Jennifer Vomaske; Michael Denton; Craig Kreklywich; Takeshi Andoh; Jessica M Osborn; Daniel Chen; Ilhem Messaoudi; Susan L Orloff; Daniel N Streblow
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.